Breaking News, Collaborations & Alliances

Batavia Biosciences Partners with VBC & MEVAC to Enhance Vaccine Manufacturing Capabilities in Egypt

Aims to deliver affordable and accessible vaccine solutions to regions where they are most needed.

Author Image

By: Charlie Sternberg

Associate Editor

Image courtesy of jorono from Pixabay.

Batavia Biosciences, a CDMO specializing in development and manufacturing of vaccines and viral vectors, has partnered with Vaccine Biotechnology City (VBC) and MEVAC—two pioneering organizations in Egypt—to enhance local vaccine manufacturing capabilities, focusing initially on Measles, Rubella, and Rotavirus vaccines. This collaboration underscores Batavia Bioscience’s commitment to addressing global health inequities by transferring advanced technologies, and know-how to support sust...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters